ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,120 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $11,920,781 | -11.9% | 152,850 | -23.4% | 0.03% | -13.9% |
Q1 2024 | $13,523,885 | +109.9% | 199,621 | +108.6% | 0.04% | +71.4% |
Q4 2023 | $6,443,702 | +111.8% | 95,677 | +113.0% | 0.02% | +40.0% |
Q3 2023 | $3,042,461 | -46.2% | 44,927 | -43.2% | 0.02% | -31.8% |
Q2 2023 | $5,658,424 | -34.2% | 79,055 | +30.6% | 0.02% | +10.0% |
Q1 2023 | $8,603,369 | +149.4% | 60,523 | +29.3% | 0.02% | -9.1% |
Q4 2022 | $3,449,796 | +2.9% | 46,800 | -23.5% | 0.02% | -45.0% |
Q3 2022 | $3,354,000 | -15.9% | 61,169 | +1.3% | 0.04% | -9.1% |
Q2 2022 | $3,989,000 | +96.3% | 60,373 | +74.8% | 0.04% | +37.5% |
Q1 2022 | $2,032,000 | +46.5% | 34,547 | +45.7% | 0.03% | +52.4% |
Q4 2021 | $1,387,000 | +99.9% | 23,719 | +105.3% | 0.02% | +40.0% |
Q3 2021 | $694,000 | +10.0% | 11,554 | +9.8% | 0.02% | +7.1% |
Q2 2021 | $631,000 | +44.1% | 10,527 | +19.4% | 0.01% | +40.0% |
Q1 2021 | $438,000 | -50.5% | 8,818 | -50.2% | 0.01% | -64.3% |
Q4 2020 | $885,000 | +22.7% | 17,705 | +34.5% | 0.03% | -6.7% |
Q3 2020 | $721,000 | +13.2% | 13,160 | +9.4% | 0.03% | -14.3% |
Q2 2020 | $637,000 | +5.5% | 12,025 | -11.1% | 0.04% | -7.9% |
Q1 2020 | $604,000 | -22.6% | 13,522 | -13.6% | 0.04% | -5.0% |
Q4 2019 | $780,000 | -28.6% | 15,659 | -36.1% | 0.04% | -37.5% |
Q3 2019 | $1,092,000 | +67.0% | 24,506 | +54.9% | 0.06% | +56.1% |
Q2 2019 | $654,000 | -56.0% | 15,825 | -57.0% | 0.04% | -59.0% |
Q1 2019 | $1,488,000 | +16.0% | 36,798 | +8.9% | 0.10% | +16.3% |
Q4 2018 | $1,283,000 | -5.2% | 33,790 | -1.2% | 0.09% | -8.5% |
Q3 2018 | $1,353,000 | +10.7% | 34,197 | -1.8% | 0.09% | +4.4% |
Q2 2018 | $1,222,000 | +50.7% | 34,813 | +50.2% | 0.09% | +45.2% |
Q1 2018 | $811,000 | -29.4% | 23,184 | -29.9% | 0.06% | -19.5% |
Q4 2017 | $1,148,000 | +58.3% | 33,094 | +54.7% | 0.08% | +51.0% |
Q3 2017 | $725,000 | +1.5% | 21,395 | +32.0% | 0.05% | -15.0% |
Q2 2017 | $714,000 | +70.0% | 16,212 | +20.3% | 0.06% | +71.4% |
Q1 2017 | $420,000 | – | 13,480 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |